| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $2,120,992 ) |
| | 2023 | 2023 | CND LIFE SCIENCES, INC. | 9165 E. DEL CAMINO DRIVE | SCOTTSDALE | AZ | 85258-4381 | MARICOPA | USA | R44NS127696 | Cutaneous Phosphorylated Alpha-Synuclein for Detection of Prodromal Synucleinopathies | 001 | 2 | NIH | 8/23/2023 | $952,525 |
| | 2023 | 2023 | CND LIFE SCIENCES, INC. | 9165 E. DEL CAMINO DRIVE | SCOTTSDALE | AZ | 85258-4381 | MARICOPA | USA | R44AG076072 | A Diagnostic Test for Dementia with Lewy Bodies | 000 | 2 | NIH | 4/10/2023 | $1,168,467 |
| | 2023 | 2022 | CND LIFE SCIENCES, INC. | 9165 E. DEL CAMINO DRIVE | SCOTTSDALE | AZ | 85258-4381 | MARICOPA | USA | R44NS127696 | Cutaneous Phosphorylated Alpha-Synuclein for Detection of Prodromal Synucleinopathies | 000 | 1 | NIH | 5/3/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $2,332,417 ) |
| | 2022 | 2022 | CND LIFE SCIENCES, INC. | 5070 N 40TH ST STE 220 | PHOENIX | AZ | 85018-2135 | MARICOPA | USA | R44NS127696 | Cutaneous Phosphorylated Alpha-Synuclein for Detection of Prodromal Synucleinopathies | 000 | 1 | NIH | 9/12/2022 | $1,092,613 |
| | 2022 | 2022 | CND LIFE SCIENCES, INC. | 5070 N 40TH ST STE 220 | PHOENIX | AZ | 85018-2135 | MARICOPA | USA | R44AG076072 | A Diagnostic Test for Dementia with Lewy Bodies | 000 | 1 | NIH | 3/9/2022 | $1,239,804 |
| | 2022 | 2021 | CND LIFE SCIENCES, INC. | 5070 N 40TH ST STE 220 | PHOENIX | AZ | 85018-2135 | MARICOPA | USA | R44NS117214 | PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for SmallBusiness Innovation Research Grant Applications (Parent SBIR [R43/R44] ClinicalTrial Not Allowed | 000 | 2 | NIH | 5/12/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,198,087 ) |
| | 2021 | 2021 | CUTANEOUS NEURODIAGNOSTICS, LLC | 3240 E STANFORD DR | PARADISE VALLEY | AZ | 85253-7525 | MARICOPA | USA | R44NS117214 | PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for SmallBusiness Innovation Research Grant Applications (Parent SBIR [R43/R44] ClinicalTrial Not Allowed | 000 | 2 | NIH | 8/17/2021 | $1,198,087 |
|
| Issue Date FY: 2020 ( Subtotal = $1,214,227 ) |
| | 2020 | 2020 | CUTANEOUS NEURODIAGNOSTICS, LLC | 3240 E STANFORD DR | PARADISE VALLEY | AZ | 85253-7525 | MARICOPA | USA | R44NS117214 | PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for SmallBusiness Innovation Research Grant Applications (Parent SBIR [R43/R44] ClinicalTrial Not Allowed | 000 | 1 | NIH | 9/24/2020 | $1,214,227 |
|
|
